Accession; Residue; Position; Context; Kinase; PMID; Source; Conscore; ELM; BindingDomain; SMART; IUPREDScore; PDB; P3D-Acc;
Q96A00; S; 12; AQRLGKRVLSKLQSPSRARG; DAPK3; 11287002; 1; 0.02; ; -; Pfam:PP1_inhibitor; 0.5643; 0; medium;
Q96A00; S; 26; PSRARGPGGSPGGLQKRHAR; none; 18088087; 2; 0.02; ; -; Pfam:PP1_inhibitor; 0.8088; 0; medium;
Q96A00; T; 38; GLQKRHARVTVKYDRRELQR; ILK; 12030846; 1; 1.0; MOD_PKA_2; -; Pfam:PP1_inhibitor; 0.5086; 0; medium;
Q96A00; T; 38; GLQKRHARVTVKYDRRELQR; none; 11287002; 1; 1.0; MOD_PKA_2; -; Pfam:PP1_inhibitor; 0.5086; 0; medium;
Q96A00; T; 38; GLQKRHARVTVKYDRRELQR; PKC_alpha; 12604330; 1; 1.0; MOD_PKA_2; -; Pfam:PP1_inhibitor; 0.5086; 0; medium;
Q96A00; T; 38; GLQKRHARVTVKYDRRELQR; none; 15184667; 1; 1.0; MOD_PKA_2; -; Pfam:PP1_inhibitor; 0.5086; 0; medium;
Q96A00; T; 38; GLQKRHARVTVKYDRRELQR; none; 15665049; 1; 1.0; MOD_PKA_2; -; Pfam:PP1_inhibitor; 0.5086; 0; medium;
Q96A00; T; 38; GLQKRHARVTVKYDRRELQR; PKA_group; 15003508; 1; 1.0; MOD_PKA_2; -; Pfam:PP1_inhibitor; 0.5086; 0; medium;
Q96A00; T; 38; GLQKRHARVTVKYDRRELQR; PKC_alpha; 15003508; 1; 1.0; MOD_PKA_2; -; Pfam:PP1_inhibitor; 0.5086; 0; medium;
Q96A00; T; 38; GLQKRHARVTVKYDRRELQR; PKC_epsilon; 15003508; 1; 1.0; MOD_PKA_2; -; Pfam:PP1_inhibitor; 0.5086; 0; medium;
Q96A00; T; 38; GLQKRHARVTVKYDRRELQR; PKD1; 15003508; 1; 1.0; MOD_PKA_2; -; Pfam:PP1_inhibitor; 0.5086; 0; medium;
Q96A00; T; 38; GLQKRHARVTVKYDRRELQR; PKC_zeta; 15003508; 1; 1.0; MOD_PKA_2; -; Pfam:PP1_inhibitor; 0.5086; 0; medium;
Q96A00; S; 128; HRQPGLRQPSPSHDGSLSPL; none; 18088087; 2; 0.02; ; -; Pfam:PP1_inhibitor; 0.8503; 0; medium;
Q96A00; S; 130; QPGLRQPSPSHDGSLSPLQD; CaM-KII_alpha; 12604330; 1; 0.02; ; -; Pfam:PP1_inhibitor; 0.846; 0; medium;
Q96A00; S; 134; RQPSPSHDGSLSPLQDRART; none; 18088087; 2; 0.05; ; -; Pfam:PP1_inhibitor; 0.8519; 0; medium;
Q96A00; S; 136; PSPSHDGSLSPLQDRARTAH; none; 18088087; 2; 0.06; ; -; Pfam:PP1_inhibitor; 0.8521; 0; medium;